Abstract:Objectives: Autonomic dysfunction is a common symptom of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis; however, it has been poorly researched. The purpose of this study was to compare the clinical features, tumor occurrence, intensive care unit (ICU) admission, mechanical ventilation, imaging assessment, cerebrospinal fluid examination, disease severity, and immunotherapy in patients with anti-NMDAR encephalitis with or without autonomic dysfunction. Methods: A retrospective study of anti-NMDAR encephalitis patients diagnosed between January 2016 and April 2020 was performed at the First Affiliated Hospital of Zhengzhou University. Patients were divided into two groups according to whether they had autonomic dysfunction, and their clinical features, treatment, and prognosis were compared. Results: A total of 119 patients with anti-NMDAR encephalitis were included in this study. Seventy-three patients (61.3%) had autonomic dysfunction, while the remaining 46 (38.7%) did not. Sinus tachycardia (69.9%) was the autonomic dysfunction with the highest incidence, while the incidences of symptoms including constipation, central hypopnea, and others gradually decreased. Compared to the group without autonomic dysfunction, the prevalence of the main clinical symptoms such as epileptic seizure ( P = 0.003), involuntary movement ( P = 0.028), and decreased consciousness ( P < 0.001) were higher in the group with autonomic dysfunction, which also more frequently presented with complications such as pulmonary infection ( P < 0.001) and abnormal liver function ( P = 0.001). Moreover, the rates of ICU admission ( P < 0.001) and mechanical ventilation ( P = 0.001), as well as the modified Rankin scale (mRS) scores at admission ( P < 0.001), maximum mRS scores during the course of disease ( P < 0.001), and mRS scores at discharge ( P < 0.001) were higher in the patients with autonomic dysfunction than in those without. The number of patients in the autonomic dysfunction group who underwent ≥2 immunotherapies was also higher than that in the group without autonomic dysfunction ( P < 0.001). Conclusion: Sinus tachycardia is the most common type of autonomic dysfunction in anti-NMDAR encephalitis. Compared to patients without autonomic dysfunction, those with autonomic dysfunction had a higher incidence of epilepsy, involuntary movements, decreased consciousness, pulmonary infections, abnormal liver function, ICU admissions, and mechanical ventilation; moreover, the severity of the disease was greater, and their prognosis worse. Therefore, such patients require intensive immunotherapy.

Autonomic dysfunction in multiple sclerosis and neuromyelitis optica spectrum disorder

Non-pharmacological and drug treatment of autonomic dysfunction in multiple system atrophy: current status and future directions

Impact of the autonomic dysfunction on the quality of life in people with NMOSD and MS: An international cross-sectional study

Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders

Urinary Symptoms and Bladder Dysfunction in Patients with Neuromyelitis Optica Spectrum Disorders: Evaluation with Urodynamics and Management

Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis

Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis

Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities

Clinical Study of Autonomic Dysfunction in Patients With Anti-NMDA Receptor Encephalitis

The nutritional risk in patients with neuromyelitis optica spectrum disorder

Neurodegeneration in multiple sclerosis and neuromyelitis optica

Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies

Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy

Autonomic impairment in primary lateral sclerosis

Dysautonomia and Postural Orthostatic Tachycardia Syndrome: A Critical Analysis of Dysautonomia: How to Diagnose and Treat

Symptom progression in neuromyelitis optica spectrum disorder from ataxia through syncope to neuropathic pain: A case report

Neuromyelitis optica spectrum disorders with non opticospinal manifestations as initial symptoms: a long-term observational study

Polyautoimmunity and multiple autoimmune syndrome in patients with neuromyelitis optica spectrum disorder

Research progress on pathogenesis and clinical treatment of neuromyelitis optica spectrum disorders (NMOSDs)

Autonomic dysfunction after moderate-severe traumatic brain injury: symptom spectrum and clinical testing outcomes

Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders